PAK7 anticorps (Center)
-
- Antigène Voir toutes PAK7 Anticorps
- PAK7 (P21 Protein (Cdc42/Rac)-Activated Kinase 7 (PAK7))
-
Épitope
- Center
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PAK7 est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
- Specificité
- This antibody detects PAK5.
- Réactivité croisée (Details)
- Species reactivity (tested):Human
- Purification
- Peptide affinity chromatography
- Immunogène
- 13 amino acid peptide from near the center of human PAK5
- Isotype
- IgG
- Top Product
- Discover our top product PAK7 Anticorps primaire
-
-
- Indications d'application
-
ELISA. Western blot. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Buffer
- PBS containing 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
- Antigène
- PAK7 (P21 Protein (Cdc42/Rac)-Activated Kinase 7 (PAK7))
- Autre désignation
- PAK7 / PAK5 (PAK7 Produits)
- Synonymes
- anticorps PAK5, anticorps pak5, anticorps 2900083L08Rik, anticorps 6430627N20, anticorps Pak5, anticorps PAK-5, anticorps PAK-7, anticorps p21 (RAC1) activated kinase 5, anticorps p21 (RAC1) activated kinase 5 L homeolog, anticorps p21 protein (Cdc42/Rac)-activated kinase 7, anticorps p21 (RAC1) activated kinase 7, anticorps PAK5, anticorps pak5.L, anticorps Pak7
- Sujet
- The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6. These proteins are not activated by Cdc42/Rac binding. PAK5 was initially identified as a kinase expressed primarily in brain that while possessing a kinase domain and GTPase binding domain similar to PAK4 and PAK6, is completely different from both. Expression of PAK5 in neural based cell lines resulted in neurite outgrowth suggesting that PAK5 may be involved in regulating the cytoskeletal changes necessary for promoting neurite outgrowth. Other experiments suggest that unlike the other PAKs, PAK5 may inhibit apoptosis by phosphorylating the Bcl-2 family member Bad.Synonyms: KIAA1264, PAK-5, PAK-7, Serine/threonine-protein kinase PAK 7, p21-activated kinase 5, p21-activated kinase 7
- ID gène
- 57144
- UniProt
- Q9P286
-